Advancing Accessible Dementia Testing
We're building the future of cognitive disease monitoring—from today's wellness insights to tomorrow's clinical diagnostics. Our mission is to democratize access to at-home dementia testing through innovative cfDNA methylation technology.
Making Dementia Testing Simple and Accessible for Better Outcomes
We believe that simpler, more accessible testing empowers better cognitive disease research, accelerates drug development, and improves outcomes for patients and families. Everyone deserves convenient, affordable access to cognitive disease monitoring—whether for proactive wellness or clinical diagnosis.
Today: Wellness Foundation
CerebralScore™ provides education-first cognitive wellness insights using advanced cfDNA methylation analysis. Our at-home saliva test offers personalized wellness recommendations to support healthy brain aging.
- Non-invasive, privacy-first saliva collection
- AI-powered wellness insights and trends
- CLIA-certified lab processing
- Educational resources and personalized guidance
For informational wellness purposes only. Not medical advice or diagnostic.
Tomorrow: Clinical Diagnostics
We're developing CerebralScore™ 2.0 as a Laboratory Developed Test (LDT) for clinical dementia assessment, bringing the convenience of at-home testing to patients who need it most.
- Clinical-grade LDT for dementia screening
- Partnership with clinics and healthcare providers
- Peer-reviewed validation studies
- Improved access for underserved populations
In development — supporting our wellness mission today accelerates clinical access tomorrow.
Why This Matters
Traditional dementia testing often requires multiple clinic visits, expensive imaging, and lengthy wait times. Many patients—especially those in rural areas or with limited mobility—face significant barriers to timely diagnosis and care.
By purchasing CerebralScore™ today, you're not just gaining valuable wellness insights—you're directly supporting the development of accessible, at-home clinical testing that could help millions of people get earlier diagnoses and better care.
From Wellness to Clinical Care
Current: Wellness Platform
CerebralScore™ provides accessible cognitive wellness insights through advanced methylation analysis. Available now for individuals and families.
Status: Active
2025-2026: Clinical Validation
Publishing peer-reviewed validation studies and partnering with clinics to establish CerebralScore™ 2.0 as a reliable clinical diagnostic tool.
Status: In Progress
2027+: Clinical LDT Launch
Full clinical deployment of CerebralScore™ 2.0 LDT, enabling physicians to order at-home dementia testing for their patients.
Status: Planned
Working with Healthcare Providers
We're actively partnering with clinics, healthcare systems, and biopharma companies to bring at-home dementia testing to patients who need it most.
- Simplified testing workflows for busy clinicians
- Improved access for rural and underserved populations
- Research collaborations and validation studies
- Pharmaceutical trial support and patient monitoring
Partner With Us
Are you a clinician, healthcare administrator, or biopharma representative interested in bringing CerebralScore™ to your patients or research programs?
Your Purchase Drives Clinical Innovation
Every CerebralScore™ wellness test purchased today directly funds the development of tomorrow's clinical diagnostic tools. Help us make dementia testing accessible to everyone.
How Your Support Helps:
Fund clinical validation studies
Support LDT development
Enable clinic partnerships
Expand access to underserved areas
Introductory pricing: $749 (save $250). Regular Price: $999.
People behind CogniSci
A cross-disciplinary team spanning AI/ML, cloud, and laboratory science.
Dr. Jason Goodpaster
CEO, FounderPhD (Caltech). 10+ years in ML/AI; multiple awards.
Stealth Cofounder
Chief Science Officer, FounderExperienced liquid biopsy builder; focused on cognitive wellness monitoring.
Joon Yoo
CTO, FounderEx-Snowflake. Cloud architecture & ML Ops; scaling teams and platforms.
Buy a CerebralScoreTM test
State-of-the-art cognitive wellness insights, powered by AI.